admin

Tesla (TSLA) stock has gone off the rails – and I have the perfect penny stock to play this once-loved EV titan’s demise.  Tesla stock has dropped as much as 70% over the past year, shedding more than $700 billion in market cap.  For context, the national economies of Saudi Arabia, Switzerland, Argentina, Sweden, and
0 Comments
For investors in a wide swath of companies, 2022 was a rough year. That said, it was a downright brutal year for those invested in most tech companies. Indeed, the three stocks on this list are among the mega-cap juggernauts of the tech world. With market capitalizations ranging from $335 billion to more than $2
0 Comments
In this episode, Preston and Stig talk about the disruptive new digital currency that’s growing around the world. Bitcoin and other cryptocurrencies could eventual become a popular form of payment without limits across international boarders. This is a fascinating discussion that you won’t want to miss. IN THIS EPISODE, YOU’LL LEARN: – What is Cryptocurrency
0 Comments
A Biotech Company and an Under-The-Radar Cloud Transformation Stock to Round Out the Year Novavax, Inc. (NVAX) is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. Novavax’s coronavirus vaccine, NVX-CoV2373, is currently approved for use in the European Union (EU), Indonesia and the Philippines. Regulatory applications seeking approval for the
0 Comments
[embedded content] Another stock market prediction for 2023? Small-cap stocks will crush large caps. Going into this new year, large-cap stocks have traded around 17X forward earnings, while small-cap stocks have traded around 13X forward earnings. To put those numbers into perspective, large caps have reverted to “average” valuation levels, while small caps are trading
0 Comments
While many investors may still be reeling from the chaos of 2022, the volatility also presents contrarians with upside (and discounted) prospects among compelling tech stocks to buy. True, red ink by itself doesn’t necessarily equate to opportunity. Still, the underlying innovation sector may not stay deflated indefinitely, even with recession fears on the horizon.
0 Comments
With many stocks discounted after a rough outing in 2022, market participants may want to concentrate on compelling blue-chip stocks to buy. The reason? Established players typically enjoy a long track record of success. Ahead of an ambiguous ecosystem (at best), large capitalization firms provide a measure of confidence. In addition, it’s much easier to
0 Comments
After a bruising 2022, how will electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID) treat its loyal investors during the next 12 months? It’s hard to envision a strong bull case for LCID stock as there no clear positive catalysts. Lucid did raise capital recently, but it wasn’t “free money” by any means. Moreover, the automaker’s
0 Comments
In this article LULU BBBY WFC ULTA Follow your favorite stocksCREATE FREE ACCOUNT Chief Brand Officer and TV Personality of WWE, Stephanie McMahon delivers her keynote address at the opening of Sports Matters in conjunction with All That Matters 2016 in Singapore on September 14, 2016. Roslan Rahman | AFP | Getty Images Check out
0 Comments
Fundamentally, the narrative for value stocks to buy in Jan. (or any other month) sells itself. Even the wealthiest among us find great deals attractive. Indeed, it takes a special kind of person to deliberately acquire something that’s overvalued for no good reason. As well, the wild market volatility in 2022 brings to the table amazing
0 Comments
Shoppers line up outside a Costco to buy supplies after the Hawaii Department of Health on Wednesday advised residents they should stock up on a 14-day supply of food, water and other necessities for the potential risks of novel coronavirus in Honolulu, Hawaii, U.S. February 28, 2020. Courtesy of Duane Tanouye via REUTERS Check out
0 Comments
Biotech stocks are in high demand right now, with good reason. Indeed, these biotech companies have the potential to revolutionize the medical world and offer solutions to unmet needs, while their relevance is recession-proof. With growing demand for gene therapies, immune oncology, and precision medicine, biotech companies have a unique opportunity to impact the world
0 Comments
Burton G. Malkiel, professor emeritus of economics at Princeton University, speaks at the John C. Bogle Legacy Forum in New York, U.S., on Tuesday, Jan. 31, 2012. Peter Foley | Bloomberg | Getty Images This week, Princeton professor Burton Malkiel has published the updated, 50th anniversary edition of A Random Walk Down Wall Street: the
0 Comments
As the market continues to contend with persistent inflation, higher interest rates and the specter of a 2023 recession, stocks of even well-established companies remain at depressed prices. In other words, there are still plenty of cheap blue-chip stocks out there, many of which make for solid long-term buys. Blue-chips make for great holdings in
0 Comments
Hardly anyone, including the company’s fans, would call California-based neo-banking firm SoFi Technologies (NASDAQ:SOFI) a winner in 2022. SOFI stock lost a great deal of value that year, but this could be a setup for a multi-bagger recovery. Indeed, at least one Wall Street expert sees a favorable reward-to-risk ratio for SoFi Technologies’ investors. So,
0 Comments